Temporal Change in Brain Natriuretic Peptide After Radiotherapy for Thoracic Esophageal Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 5, 2007, Pages 1417-1423

  Jingu, Keiichi ^a   Nemoto, Kenji ^c   Kaneta, Tomohiro ^a   Oikawa, Minako ^a   Ogawa, Yoshihiro ^a   Ariga, Hisanori ^a   Takeda, Ken ^a   Sakayauchi, Toru ^a   Fujimoto, Keisuke ^a   Narazaki, Kakutaro ^a   Takai, Yoshihiro ^a   Nakata, Eiko ^a   Fukuda, Hiroshi ^b   Takahashi, Shoki ^a   Yamada, Shogo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

Brain natriuretic peptide; Esophageal cancer; FDG PET; MMP 3; Radiation induced myocardial damage

Indexed keywords

BRAIN; CONCENTRATION (PROCESS); ONCOLOGY; PEPTIDES;

BRAIN NATRIURETIC PEPTIDES; ESOPHAGEAL CANCER; RADIATION-INDUCED MYOCARDIAL DAMAGE;

RADIOTHERAPY;

BRAIN NATRIURETIC PEPTIDE; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BIOACCUMULATION; CANCER PATIENT; ESOPHAGUS CANCER; FEMALE; HEART MUSCLE INJURY; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CA-15-3 ANTIGEN; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 36148958971     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.05.054     Document Type: Article

References (24)

1. Murakami M., Kuroda Y., Nakajima T., et al. Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma. Int J Radiat Oncol Biol Phys 45 (1999) 277-284
2. Hironaka S., Ohtsu A., Boku N., et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57 (2003) 425-433
3. Yamada S., Nemoto K., Takai Y., et al. Proposal for standard radiotherapy methods for superficial esophageal cancer. A multicenter retrospective evaluation. J JASTRO 12 (2000) 169-176
4. Jingu K., Nemoto K., Kaneta T., et al. A case of high FDG-uptake into the myocardium after radiotherapy for esophageal cancer. Nippon Igaku Hoshasen Gakkai Zasshi 65 (2005) 266-269
5. 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage. Int J Radiat Oncol Biol Phys 66 (2006) 845-851
6. Saito Y., Nakao K., Yamada T., et al. Brain natriuretic peptide is a novel cardiac hormone. Biochem Biophys Res Commun 158 (1989) 360-368
7. Kambayashi Y., Nakao K., Mukoyama M., et al. Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett 259 (1990) 341-345
8. Mukoyama M., Nakao K., Hosoda K., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87 (1991) 1402-1412
9. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
10. Dollery C.M., McEwan J.R., and Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circ Res 77 (1995) 863-868
11. Galis Z.S., Muszynski M., Sukhova G.K., et al. Cytokine stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75 (1994) 181-189
12. Nagase H., and Okada Y. Proteinases and matrix degradation. In: Kelly W.N., Harris E.D., Ruddy S., et al. (Eds). Textbook of rheumatology (1997), W.B. Saunders, New York 323-341
13. Spinale F.G., Coker M.L., Bond B.R., et al. Myocardial matrix degradation and metalloproteinase activation in the failing heart: A potential therapeutic target. Cardiovasc Res 46 (2000) 225-238
14. Wondergem J., Persons K., Zurcher C., et al. Changes in circulating atrial natriuretic peptide in relation to the cardiac status of Rhesus monkeys after total-body irradiation. Radiother Oncol 53 (1999) 67-75
15. Wondergem J., Strootman E.G., Frolich M., et al. Circulating atrial natriuretic peptide plasma levels as a marker for cardiac damage after radiotherapy. Radiother Oncol 58 (2001) 295-301
16. Kruse J.J., Strootman E.G., Bart C.I., et al. Radiation-induced changes in gene expression and distribution of atrial natriuretic peptide (ANP) in different anatomical regions of the rat heart. Int J Radiat Biol 78 (2002) 297-304
17. Meinardi M.T., van Veldhuisen D.J., Gietema J.A., et al. Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients. J Clin Oncol 15 (2001) 2746-2753
18. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350 (1997) 1349-1353
19. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
20. Schimmel K.J., Richel D.J., van den Brink R.B., et al. Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev 30 (2004) 181-191
21. Rutqvist L.E., Lax I., Fornander T., et al. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 22 (1992) 887-896
22. Gyenes G., Rutqvist L.E., Liedberg A., et al. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 48 (1998) 185-190
23. Chandra A., Guerrero T.M., Liu H.H., et al. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol 77 (2005) 247-253
24. Wu V.W., Sham J.S., and Kwong D.L. Inverse planning in three-dimensional conformal and intensity-modulated radiotherapy of mid-thoracic oesophageal cancer. Br J Radiol 77 (2004) 568-572